DVA Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio20.27Forward 14.51
EPS (TTM)$10.3943.5% YoY
Profit margin5.7%HEALTHCARE
Market cap$13.52BLarge cap
Wall Street coverage
$193.71median target· current $140.24 (+38.1%)8 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 14.51
- PEG ratio
- 0.65
- P/B
- 21.63
- P/S (TTM)
- 0.98
- EV/EBITDA
- 9.63
Profitability & growth
- ROE (TTM)
- 81.0%
- Operating margin
- 13.9%
- Revenue growth YoY
- 6.0%
- Dividend yield
- —
- Beta
- 0.91
Last earnings
May 5, 2026 · Estimate $2.33 · Reported $2.87
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
46 articles · sorted by datePage 1 of 3 · 46 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About DaVita HealthCare Partners Inc
Company profileDaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.
Classification
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 2000 16TH STREET, DENVER, CO
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$13.52B
Shares outstanding$64.2M
52W high$213.44
52W low$101.00
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent